Letter to the Editors
Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
Dai Maruyama
, Hirokazu Nagai, Noriko Fukuhara, Toshiyuki Kitano, Takayuki Ishikawa, Tomoaki Nishikawa
著者情報
キーワード:
covalent BTK inhibitor,
ibrutinib,
Japanese patients,
mantle cell lymphoma,
phase II clinical trial
2019 年 59 巻 2 号 p. 98-100
詳細
記事の1ページ目
